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Eppendorf, Hamburg, Germany; and 5Theory Department, Fritz-Haber-Institut der Max-Planck-Gesellschaft, Berlin, GermanyABSTRACT Von Willebrand factor (VWF) plays a central role in hemostasis. Triggered by shear-stress, it adheres to platelets
at sites of vascular injury. Inactivation of VWF has been associated to the shielding of its adhesion sites and proteolytic cleavage.
However, the molecular nature of this shielding and its coupling to cleavage under shear-forces in flowing blood remain un-
known. In this study, we describe, to our knowledge, a new force-sensory mechanism for VWF-platelet binding, which addresses
these questions, based on a combination of molecular dynamics (MD) simulations, atomic force microscopy (AFM), and micro-
fluidic experiments. Our MD simulations demonstrate that the VWF A2 domain targets a specific region at the VWF A1 domain,
corresponding to the binding site of the platelet glycoprotein Iba (GPIba) receptor, thereby causing its blockage. This implies
autoinhibition of the VWF for the binding of platelets mediated by the A1-A2 protein-protein interaction. During force-probe
MD simulations, a stretching force dissociated the A1A2 complex, thereby unblocking the GPIba binding site. Dissociation
was found to be coupled to the unfolding of the A2 domain, with dissociation predominantly occurring before exposure of the
cleavage site in A2, an observation that is supported by our AFM experiments. This suggests that the A2 domain prevents
platelet binding in a force-dependent manner, ensuring that VWF initiates hemostasis before inactivation by proteolytic
cleavage. Microfluidic experiments with an A2-deletion VWF mutant resulted in increased platelet binding, corroborating the
key autoinhibitory role of the A2 domain within VWF multimers. Overall, autoinhibition of VWF mediated by force-dependent
interdomain interactions offers the molecular basis for the shear-sensitive growth of VWF-platelet aggregates, and might be
similarly involved in shear-induced VWF self-aggregation and other force-sensing functions in hemostasis.INTRODUCTIONVon Willebrand Factor (VWF) is a giant extracellular pro-
tein playing a key adhesive role in blood clotting. Activated
by shear-stress, this protein cross-links the extracellular
matrix of the endothelium with blood platelets, at sites
of vascular injury (1,2). It efficiently participates in the
shear-induced reversible formation of biopolymer-colloid
aggregates (3), and its malfunction leads to pathological
bleeding and thromboembolic disorders (1).
Functional VWF is a linear multimer of tens of covalently
linkedmonomers (4), extending up to 15mm (5). Eachmono-
mer,with a length of 60 to 80 nm (2,6), comprises 2050 amino
acids in domains of few nm in size (7). The large size in the
mm range enables VWF multimers to sense changes in the
shear flow of blood and to translate them into a mechanical
stretching force along the protein chain (5,8,9). Shear-forces,
by inducing a tumbling motion alternating between globular
and extended states, facilitate the adhesion of VWF to the
extracellular matrix (5,10) and to flowing platelets (3).Submitted October 10, 2014, and accepted for publication March 18, 2015.
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0006-3495/15/05/2312/10 $2.00The VWF A1 and A2 domains are critical for the activa-
tion of VWF to bind platelets and for its deactivation by
size control. These two domains are adjacent to each other
and connected by a linker of  30 amino acids (Fig. 1 A).
X-ray crystallography revealed that both domains adopt a
stable Rossmann a/b-fold (11,12), stabilized by calcium
in the case of A2 (13,14). Platelets bind through the glyco-
protein Iba (GPIba) to a region of the A1 domain (15,16),
in a shear-dependent manner (17–21). For size control, the
A2 domain is cleaved by the metalloprotease ADAMTS13
(22), after exposure of the Y1605-M1606 (YM) cleavage
site, because of shear-induced domain unfolding (23–27).
Under equilibrium or under low shear-stress conditions,
VWF is incapable of binding platelets. This inactivation
has been associated with a shielding of the GPIba binding
site of A1. Recent experiments revealed that, in addition
to the D’D3 domains (28) and the linker connecting them
to the A1 domain (29), isolated A2 domains modulate
glycoprotein Ib (and thereby platelet) binding (30,31). How-
ever, electron microscopy (EM) images established the sep-
aration between these two domains, within the same VWF
molecule, from 4.4 to 11 nm (6), challenging the inhibitoryhttp://dx.doi.org/10.1016/j.bpj.2015.03.041
FIGURE 1 Blockage of the GPIba binding site in the VWF revealed by
MD simulations of the VWF A1 and A2 domains. (A) Scheme illustrating
the human VWF-A1A2 fragment (residues 1269 to 1670). The A1 and A2
domains are connected by a 30 residue linker (yellow). GPIba anchors
platelets to VWF by binding to the A1 domain. VWF size is controlled
by cleavage of the unfolded A2 domain by ADAMTS13. O-linked (cyan)
and N-linked sugars (N-sugars, orange) are found within the fragment.
(B) One of the multiple starting conformation used in the MD simulations
(protein as cartoon and surface and sugars as sticks). The domain-domain
center of mass (A1-A2) separation is indicated with the black arrow. (C)
A1-A2 separation along the concatenated MD simulation time. Gray lines
separate individual MD runs. The right plot shows the normalized histo-
gram of the A1-A2 separation. Conformations at the bottom show examples
with the two domains in contact (cartoon) contrasted to the region occupied
by GPIba when it binds to A1 (red surface), taken at the instants marked
with the red symbols. (D) GPIba binding site accessible surface (GPIba-
BS-AS) as a function of the A1-A2 separation (main panel) and its normal-
ized histogram (right plot), recovered from MD simulations. Reduced
GPIba-BS-AS values indicate blockage of the GPIba binding site. The
GPIba-BS-AS derived from the VWF A1-GPIba complex x-ray structure
(16) is depicted by the cyan line. The red symbols correspond to the confor-
mations shown in (C). To see this figure in color, go online.
Von Willebrand Factor Autoinhibition 2313role of A2 on A1. Hence, little is known on how these two
domains interact with each other, causing inhibition, and
how sensitive this interaction is to shear-forces in flowing
blood. It also remains unclear how VWF activation, through
the release of the GPIba binding site, and VWF deactivation,through unfolding of the A2 domain, are mechanically
regulated to balance the propagation and attenuation of
hemostasis. We addressed these questions by performing
molecular dynamics (MD) simulations of the VWF A1 and
A2 domains, under equilibrium and force-probe conditions,
together with molecular docking calculations, atomic force
microscopy (AFM) binding measurements, and microfluidic
experiments. To our knowledge, our results suggest a novel
mechanism for shear-dependent primary hemostasis,
involving a force-sensitive autoinhibition state, in which
platelets are incapable to bind to VWF because of direct
(intra- or intermolecular) A1-A2 interactions precluding
the A1-GPIba interaction.MATERIALS AND METHODS
Equilibrium MD simulations
In the first simulation system, the A1 and A2 domains of the VWF were
not covalently connected by their interdomain linker. They were either
initially separated by distances from 6.1 to 8.6 nm to monitor association
or already bound in conformations blocking the GPIba binding site
(obtained by docking, see below) for refinement. The second simulation
system corresponded to the VWF-A1A2 fragment consisting of the A1
and A2 domains connected by a 30 amino acid linker, with an initial in-
terdomain separation of 7.9 nm based on EM estimates (6). The most pre-
dominantly found sugars in the VWF glycome (32,33) were attached to
the protein (Fig. 1 A and Fig. S1 in the Supporting Material). Simulations
were carried out with the GROMACS package (4.5 version) (34–36).
Sixteen or 17 runs, considering multiple interdomain initial orientations,
were performed for each condition (R 82 ns per run) yielding a concate-
nated simulated time of 4.86 ms. The GPIba binding site accessible
surface (GPIba-BS-AS) was computed by monitoring the amount of
exposed surface of the GPIba binding site in the A1 domain. A principal
component analysis (PCA), consisting in the calculation and diagonaliza-
tion of the covariance matrix of the atomic coordinates (37), was em-
ployed to monitor the interdomain orientations (Fig. 2). The solvent
accessible hydrophobic surface (SAHS) reduction was estimated as
[SAHS(A1A2)  SAHS(A1)  SAHS(A2)]/[SAHS(A1) þ SAHS(A2),
computing separately the surface for the complex (A1A2) and for the
domains A1 and A2.Force-probe MD simulations
The A1 and A2 domains of the VWF were subjected to external harmonic
forces on the N-terminus of the A1 domain and on the C terminus of
the A2 domain (Fig. 3 A). Harmonic springs (with elastic constants of
500 kJmol–1nm–2) were attached to these termini and moved away from
each other at a speed of 0.2 m/s. These simulations were started from 17
different starting conformations: one was extracted from an equilibrium
MD run showing spontaneous binding (run number eight in Fig. 1 C) and
the remaining 16 corresponded to representative conformations of the equi-
librium simulations of the VWF-A1A2 complex (one conformation taken
from each run presented in Fig. 2 A). Hence, starting conformations with
high but also moderate stability were considered. The two monomers
were not connected, first, to resemble dissociation of the A1-A2 complex
either within or across VWF monomers (preventing from possible artifacts
by the inclusion of the flexible linker for which the structure is unknown),
and second, to have a direct comparison with our AFM experiments (also
carried out with nonconnected domains, see below). Dissociation was
assigned to the moment when the interdomain number of contacts was
zero. Detachment of the A2-b5 strand from the core of the A2 domainBiophysical Journal 108(9) 2312–2321
FIGURE 2 Orientational preferences of the VWF-A1A2 complex in the
blocked state. (A) Principal component analysis (PCA) of the structures of
the not-covalently linked VWF-A1A2 complex, with the GPIba binding
site blocked, predicted by molecular docking, yielded two main collective
vectors (eig1 and eig2). MD trajectories (the last 50 ns) starting from these
structures were projected onto the two-dimensional (2D) space created by
these two vectors (projections in arbitrary units). Each dot, representing a
simulation snapshot, reflects an adopted interdomain orientation. Each
run is colored according to its interdomain potential interaction energy,
V, and average solvent accessible hydrophobic surface reduction, SAHSR
(see B). Representative orientations of runs with both high V and SAHSR
(enclosed by the red circle in B) are displayed (A1 domain, white; A2
domain, color; b3 strands, cartoon; A2 b6 strand, ribbon, and A2 C termi-
nus, sphere). The red arrows illustrate the change in orientation of A2 on
horizontal changes in the 2D-PCA space. (B) SAHSR as a function of V
(time-average5 standard deviation from the last 50 ns of each run). Colors
indicate the projection along a linear fit (black line), with both V and
SAHSR ranging from small (light green) to large (blue) values. To see
this figure in color, go online.
FIGURE 3 Force response of the VWF-A1A2 complex from force-probe
MD simulations. (A) The N-terminus (Nt) of the A1 domain and the C ter-
minus (Ct) of the A2 domain were pulled away from each other by har-
monic springs. The domains were initially in contact but not connected
by a linker (domains in cartoon and N-linked sugars in stick representa-
tion). (B) Snapshot illustrating a typical dissociation event of the
VWF-A1A2 complex induced by the applied force (same representation
as in A). Slight unfolding of the C-terminal part of the A2 domain was
observed. The disulfide bond Cys1272-Cys1458 (C-C) prevented the A1
domain from unfolding. (C) Cumulative dissociation events (from 17
runs) as a function of the distanceDee between the pulled N- and C termini
at the moment of dissociation. Here, DD ¼ Dee  Deeð0Þ, subtracting the
initial distance Deeð0Þ, is shown. The Y1605-M1606 (YM) ADAMTS13
cleavage site was exposed after separation of the A2 C-terminal b5 strand
from the core of the protein (event indicated by the dotted line). The black
circle corresponds to the dissociation event illustrated in (B). To see this
figure in color, go online.
2314 Aponte-Santamarı´a et al.was monitored by measuring the distance between V1625-P1627 (at b5)
and V1604-Y1605 (at b4).Molecular docking
To augment the MD-generated conformational ensemble of the VWF-
A1A2 complex, with a blocked GPIba binding site, we used molecular
docking. Two independent docking approaches, either using Patchdock
(38) with further refinement with Firedock (39) or using RosettaDock
(40) were considered. Starting conformations of the MD simulations withBiophysical Journal 108(9) 2312–2321the domains in contact were generated by Patchdock and Firedock (see
selection criterion in Fig. S3).Cloning, expression, and purification of VWF
constructs
The cDNAs coding for either the full-length human VWF, or the A1, A2,
and A3 domain, the latter three with 6x His-tag, were cloned into the
mammalian expression vector pcDNA3 (41). DA1-VWF and DA2-VWF
mutants were obtained by deleting either the A1 or the A2 domain from
the full-length cDNA, by site-directed mutagenesis, employing the Quick-
Change kit (Stratagene, La Jolla, CA). All primers are available on request.
Recombinant expression of VWF constructs in HEK293-EBNA cells was
performed as described (42) and the His-tagged VWF domain constructs
were purified employing the His-Pur Ni-NTA Resin (Thermo Scientific,
Waltham, MA).AFM
Force distance cycles (FDC) were acquired by approaching and retracting
the VWFA1 domain (C-terminally linked to the AFM cantilever by malei-
mide-polyethylene glycol (PEG)-NHS -mPN- molecules) to VWF A2 do-
mains (C-terminally immobilized on a mica surface by mPN linkers).
The disulfide bond Cys1272-Cys1458, connecting the N- and C terminus
of the A1 domain, ensured a high similarity of the pulling geometry in
Von Willebrand Factor Autoinhibition 2315the force-probe MD simulations (pulling the N-terminus) and the AFM ex-
periments (pulling the C terminus). Binding events were discerned from
nonspecific adhesion by how much they differed in the approach and retrac-
tion force signals. To have an unbiased choice of binding events, FDC dis-
playing a characteristic worm-like-chain-type force signal, as well as FDC
not showing such behavior, were included for further analysis. To validate
specific binding, control experiments were carried out either in the presence
of 0.1 mg/ml soluble A2 domains or by replacing either the A1 or the A2
domain by VWF A3 domains. The latter case constitutes a critical control
experiment, because A3 is a protein domain that is in the vicinity of A1
and A2 in physiological conditions, and also has the Rossmann topology.
For each system, four cantilever tips were utilized. At least 1000 FDC
were recorded for each of the tips at a pulling speed of 600 nm/s.
The elongation L corresponded to the extension of the A1 and A2
domains, together with the ones of the mPN linkers and 3-aminopropyltrie-
thoxy silane (APTES) coating molecules. It was measured, during a binding
event, as the distance in which the attraction and retraction force-distance
curves differed minus the cantilever deflection CD (Fig. 4 A). In practice,
Lþ CD was measured by fitting a second-order polynomial to the force
curves, followed by the determination of the point in the retraction curve
where the force abruptly returned back to zero. The cantilever deflection
CD was determined as the applied stretching force F (extracted at the
moment of rupture during the FDC) divided by the actual spring constantFIGURE 4 Force response of the VWF-A1A2 complex from AFM. (A)
Typical approach-retraction force-distance profiles associated to no-binding
and binding events. The elongation L, of the A1 and A2 domains, together
with the mPN linkers and the 3-aminopropyltriethoxy silane coating mole-
cules, summed to the cantilever deflection (CD) was determined by the
difference between approach and retraction curves. (B) (1) Number of bind-
ing events between VWFA1 and A2 domains. A1 was connected to the tip
of the AFM cantilever (triangle) using malemide-PEG-NHS (mPN) linkers.
It was approached to and retracted from the surface carrying mPN-linked
A2 domains. Force-distance cycles presented in (A) correspond to this sit-
uation. (2–4) Number of binding events measured in control AFM experi-
ments, in which the A1 domain was blocked by soluble A2 domains (2), or
either the A2 domains on the surface (3) or the A1 domain connected to the
cantilever (4) were replaced by VWFA3 domain. (C) Cumulative distribu-
tion of L (black line) and its correction by subtracting the size of A1 and the
mPN linkers (gray area). Dotted line indicates the expectation value (EV)
of L. To see this figure in color, go online.of the cantilever (30 pNnm–1). The expectation value of L (EV) was esti-
mated as EV ¼PiPiLi, with Pi the measured probability to have an elon-
gation of Li, summing over all the measured Li values. To account for the
size of the A1 domain and the mPN linkers, lA1 þ 2ll was subtracted to each
measured elongation L. The size of the A1 domain (lA1) was estimated as 2
 its radius of gyration (1.6 nm, derived from MD simulations of the iso-
lated A1 domain (43)). Aworm-like-chain model was employed to compute
the extension ll of the mPN linkers as a function of the force F. It reads as
follows:
FP
kBT
¼ 1
4

1 ll
lc
2
 1
4
þ ll
lc
;
where P is the persistence length (0.38 nm (44)), lc is the mPN linker con-
tour length (8.9 nm, considering 27 PEG units and 0.33 nm per unit), kB
is the Boltzmann constant, and T is the temperature. The cumulative distri-
butions of both the original elongation L and its theoretical reduction
(accounting for the size of A1 and linkers) were shown.Microfluidic experiments
For distinct shear rate application, air-pressure driven microfluidic channels
were coated with recombinant wild-type VWF, DA2-VWF, or DA1-VWF.
For the functional characterization, the coated microfluidic channels were
mounted onto an inverted fluorescence microscope and perfused, as previ-
ously published (45), with wild-type VWF, VWF with the A2 domain
deleted, or VWF with the A1 domain deleted. Live cell fluorescence images
were taken and analyzed at shear rates in the range of 500 s–1 to 4000 s–1. To
track the motion of VWF-platelet fibers and aggregates, an image compo-
sition of 20 sequential frames (taken at a frequency of two frames/s) was
implemented. Increasing number of frames was considered for the compo-
sition (from one to all 20 frames), subtracting identical pixels among
frames. Dynamical monitoring allowed the exact determination of the crit-
ical shear rate for VWF-platelet fiber and aggregate formation.
See further details of the simulations and the experimental procedures in
the Supporting Material.RESULTS
Blockage of the VWF GPIba binding site in A1
by A2
We first investigated whether the VWF A2 domain sponta-
neously binds to the A1 domain. To this end, we carried
out 17 independent 100 ns equilibrium MD simulations,
starting with these two domains separated by distances
(between their center of masses) from 6.1 to 8.6 nm and
adopting different orientations with respect to each other
(Fig. 1 B). The linker connecting the two domains was not
considered (in the following, this situation will be referred
as not connected domains). The two domains spontaneously
came into contact and remained stably bound in seven out of
17 simulation runs, as reflected by drops in their separation
to values smaller than 5 nm (Fig. 1 C).
We next analyzed if the GPIba binding site in the A1
domain was blocked upon binding of the A2 domain. We
quantified the amount of blockage by computing the GPIba
binding site accessible surface (GPIba-BS-AS) (Fig. 1 D).
The GPIba-BS-AS histogram recovered from our simula-
tions revealed a major peak close to the value estimatedBiophysical Journal 108(9) 2312–2321
2316 Aponte-Santamarı´a et al.from the x-ray structure of the VWF A1-GPIba complex
(16) (33.4 nm2), indicating no blockage. In addition, the his-
togram contained a tail extending to values smaller than
20 nm2, reflecting substantial blockage (of more than 40%
of the x-ray GPIba-BS-AS). Remarkably, blockage was
found correlated with the separation between domains,
with the GPIba binding site fully accessible (large GPIba-
BS-AS) only for large interdomain separations, whereas
completely blocked (small GPIba-BS-AS) when the A2
domain approached the A1 domain. Thus, from our simula-
tions, A2 binding to A1 implies blockage of the VWF-
GPIba interaction site.
We also tested the blockage of the GPIba binding site
within a VWF-A1A2 fragment, with the A1 and A2 do-
mains connected by the linker. We simulated the dynamics
of such fragment, in 16 independent MD runs of 82 to
100 ns, with initial interdomain separations ( 7.9 nm)
and linker extensions ( 6.0 nm) taken from EM estimates
(6) (Fig. S2 A). The fragment populated the lower range of
separations measured in the EM experiments (6) (Fig. S2 B).
Again, the MD-generated conformations included several
instances of direct A1-A2 interactions (Fig. S2 B). The pres-
ence and involvement of the O-linked glycosylated linker
now alleviated the strong correlation between A1-A2 bind-
ing and blockage of the GPIba binding site as observed for
not connected domains (Fig. S2 C).Orientational preferences in the blocked state
Our simulations raised the question on the most-favorable
conformation of the two domains with GPIba binding
blocked. We addressed this by performing molecular dock-
ing followed by MD refinement. We generated a set of
conformations by docking the A2 domain to the A1
domain. From this set, we selected representative confor-
mations with both the GPIba binding site blocked and
high docking score as starting positions of 16 MD simula-
tions of 100 ns each (see Fig. S3 and the Supporting
Material for the selection criterion). Similar conformations
presenting blockage were predicted by two independent
docking approaches (Fig. S4). Furthermore, an enrichment
of blocked conformations over random conformations
was observed, because of their large interdomain shape
complementarity and favorable protein-protein interac-
tions, thus justifying our selection criterion of only
blocked and high-docking-score structures (Fig. S5 and
the Supporting Material).
During the simulations the domains remained bound
causing blockage, while maintaining their internal structure
almost intact (backbone root-mean-square deviation to the
initial structure below 1.5 A˚ for A1 and 2.3 A˚ for A2), but
accommodating with respect to each other in multiple orien-
tations. To capture the extent of stable blocking interdomain
orientations we carried out a PCA of the conformations
predicted by docking (yielding two main collective eigen-Biophysical Journal 108(9) 2312–2321vectors covering 68% of the possible interdomain orienta-
tions), followed by projections of the MD trajectories onto
the two-dimensional (2D) space generated by these two vec-
tors (Fig. 2 A). Furthermore, we narrowed the orientations to
those with high interdomain potential energy, V, and sub-
stantial solvent accessible hydrophobic surface reduction
(SAHSR) (Fig. 2 B). Remarkably, in all orientations with
large Vand SAHSR contributions, the A2 domain was found
directly obstructing the A1-domain b3 strand (the one con-
necting with GPIba (15,16)) and displaying only small
orientational deviations (small point clouds in the 2D-
PCA projections), indicating high structural integrity.
Within this preferred set of VWF-A1A2 complexes, the
A2 domain oriented in two main modes: either with its C
terminus in proximity to the A1 domain or—on ~180 rela-
tive rotation—with its b3 strand in proximity, almost form-
ing a stable interdomain b-sheet in the latter case (compare
top with bottom projections and snapshots in Fig. 2 A). The
residues Arg1668 and Asp1587, both in A2, were found to
strongly interact with A1: Arg1668, when the C terminus
was in proximity to A1, and Asp1587, when the b3-strand
was in vicinity. Destabilizing mutations Arg1668Asp and
Asp1587Lys are thus potential candidates to detect the
most favored conformation of the complex among the two
observed orientational modes. In addition, replacement of
Val1548 located directly at the b3 strand of A2, for instance
by a bulky polar residue such as serine or asparagine, would
further distort the orientational mode that features a quasi
interdomain b-sheet.
We validated the observed orientational preferences
by comparing this with our previous set of simulations
(Fig. S6). The docking-MD refined region was also
sampled during the MD simulations starting from separated
domains, with the A2 domain located directly in front of
the b3 strand of the A1 domain. However, the conforma-
tional ensemble in the blocked state was further broadened
presumably because of the sugars and also the linker
between A1 and A2.VWF-A1A2 complex under force: activation
versus cleavage
Induced by shear-forces, the release of the GPIba binding
site in the A1 domain would allow platelet-binding
activation, whereas exposure of the YM catalytic site after
unfolding of the A2 domain would enable cleavage and
degradation. We studied how a stretching force balances
these two processes. For this purpose we performed 17
independent force-probe MD simulations, starting from a
diverse set of conformations of the two domains, not con-
nected, forming a complex, and with the GPIba binding
site obstructed (Fig. 3 A). We pulled the N-terminus
of the A1 domain and the C terminus of the A2
domain away from each other, until dissociation of the
complex (and thereby unblocking of the GPIba binding
FIGURE 5 Changes in shear-induced fiber and aggregate formation on
deletion of the VWF A2 domain. Live-cell fluorescence images of
platelet-decorated VWF fibers and platelet-VWF aggregates observed in
microfluidic experiments at the indicated shear rates (different columns).
Microfluidic channels were perfused with plasmatic wild-type VWF (wt-
Von Willebrand Factor Autoinhibition 2317site) occurred (Fig. 3 B). The A2 domain slightly unfolded
in its C-terminal part, while the A1 domain remained
folded because of its Cys1272-Cys1458 disulfide bond
(Fig. 3 B).
We quantified the extent of unfolding of the C terminus of
the A2 domain by monitoring the increase in the distance be-
tween the pulled termini,Dee, with respect to the initial dis-
tanceDeeð0Þ. Exposure of theYMcleavage site, as an initial
requirement for ADAMTS13 cleavage, occurred after the
detachment of the b5 strand (Dee  Deeð0Þx13:6 nm).
In comparison, dissociation of the fragment, as needed for
activation, occurred before YM exposure, in 15 of the 17
runs (88% of the cases) (Fig. 3 C).
We next probed the physical interaction between A1 and
A2 and the coupling between dissociation and unfolding, as
suggested by our simulations, at the single-molecule level
by using AFM (Fig. 4). FDC were acquired by approaching
the A1 domain (linked to the AFM cantilever) to A2 do-
mains (immobilized on a surface) and retracting it again.
A retracting force signal differing from the approaching
one, with an abrupt drop to zero at dissociation, was used
as an indicator for a binding event (Fig. 4 A). It was
observed in ~23% of the cycles (1 in Fig. 4 B). In contrast,
a substantially reduced number of binding events (less than
10%) was observed in the presence of soluble A2 domains,
presumably because of the blocking of the A1 domain at the
cantilever (2 in Fig. 4 B). As a control, reduction in the
number of binding events was also observed when replacing
either the A2 domains at the surface (3 in Fig. 4 B) or the
A1 domain at the cantilever (4 in Fig. 4 B) by VWF A3
domains. This implies that binding events are exclusively
through A1-A2 interactions, thus confirming the observa-
tion from our MD simulations and from previous binding as-
says (30) that the VWF A1 and A2 domains specifically
interact.
To further investigate the coupling between dissociation
of the VWF-A1A2 complex and unfolding of the A2
domain, we measured the elongation of the complex
(together with linkers and coating molecules) before disso-
ciation by AFM (Fig. 4 C). The measured expectation
value of the elongation (~28 nm) was substantially lower
than the extension of a fully stretched unfolded A2 domain
(~80 nm (23–27)). In fact, in all FDC, the elongation
remained below those levels of extension. Although the
noise in the length distribution is expected to be large
because of the tip and surface chemistry, our AFM data
speak against full unfolding of A2 before dissociation.
Instead, it suggests a small extent of unfolding of A2
before dissociation.VWF, top row), VWF with the A2 domain deleted (DA2-VWF, middle
row), or VWF with the A1 domain deleted (DA1-VWF, bottom row). A
static image is presented as background, displaying platelets, fibers, and ag-
gregates in black. Moving fibers and aggregates are highlighted in color.
Their positions were tracked during 10 s after taking the static image.
Flow direction is indicated with the arrow and the line corresponds to
100 mm. To see this figure in color, go online.Functional characteristics of VWF with the A2
domain deleted in shear-induced fiber formation
We next examined if the A2 domain inhibits VWF-platelet
binding in a shear-dependent manner, by performing micro-fluidic experiments, in wild-type VWF-coated channels,
under replacement of the plasmatic wild-type VWF by re-
combinant VWF with the A2 domain deleted (DA2-
VWF), and in a wide shear range. In the presence of
wild-type VWF in the perfusion medium, above a critical
shear rate of 4000 s–1, large aggregates of VWF and plate-
lets were observed to roll along the surface coated with
VWF (Fig. 5, top right). At lower shear rates, rolling
VWF-platelet aggregates were absent. Here, we only
observed either rolling of single platelets along the micro-
fluidic channel (at 500 s–1, Fig. 5, top left) or reversibly
formed platelet-decorated VWF fibers, which stayed
attached to the channel surface (at 2500 s–1, Fig. 5, top mid-
dle). Instead, in the presence of DA2-VWF in the perfusion
medium, the critical shear rate for rolling aggregate forma-
tion was decreased to 2500 s–1, indicating a gain of function
for the VWF by deletion of its A2 domain (Fig. 5, middle,
and Movie S1). Identical results were obtained using
DA2-VWF instead of wild-type VWF for coating of the
microfluidic channels (data not shown). In a multimer anal-
ysis, similar VWF size distributions were observed for the
mutants and for the wild-type VWF, just slightly shifted
down because of the deletions in the mutant proteins
(Fig. S7). Changes in the VWF distribution size are thus
discarded as the reason for the gain in function of the
DA2-VWF mutant. As expected, neither fibers nor VWF-
platelet aggregates were formed in the presence of VWF
with an A1-domain deletion (Fig. 5, bottom). Furthermore,
coating with DA1-VWF led to a complete absence of
both single platelet rolling and the formation of rollingBiophysical Journal 108(9) 2312–2321
2318 Aponte-Santamarı´a et al.VWF-platelet aggregates independent of the VWF present
in the perfusion medium.DISCUSSION
Blockage of the GPIba binding site mediated by
A1-A2 interactions implies autoinhibition
Our extensive set of simulations (in the ms time range) dem-
onstrates that the GPIba binding site of VWF (located in the
A1 domain) can be significantly blocked, upon spontaneous
binding of the A2 to the A1 domain (Fig. 1). In addition, the
binding of these two domains was further confirmed at the
single-molecule level by AFM (Fig. 4). The increase in
blockage with reducing interdomain separation observed
in our simulations suggests that the A2 domain does not
recognize a random region in the A1 domain but instead it
specifically targets the GPIba binding site. This observation
was further supported by our docking calculations, which
showed enrichment toward blocked conformations over
random conformations, by enhanced shape complemen-
tarity and favorable protein-protein interactions (Fig. S5).
With the GPIba binding site blocked, platelets are prevented
to bind and thus the VWF remains inactive. Our results,
together with the experimentally observed platelet-binding
modulation in the presence of A2 domains (30), thus imply
an autoinhibition mechanism for the binding of platelets to
the VWF mediated by A1-A2 interactions.
Additional simulations, this time with the two domains
connected (also in the ms time range), revealed broad dy-
namics of the VWF-A1A2 fragment (Fig. S2). Although
the A2 domain (bound to the A1 domain) was sometimes
observed causing no shielding, presumably stabilized by
the connecting linker, it was also found in many other times
substantially blocking the GPIba binding site. This indi-
cates that not only not connected, but also vicinal, cova-
lently linked, A1 and A2 domains can interact with each
other causing blockage, further supporting the hypothesis
of VWF autoinhibition because of A1-A2 interactions.
Our simulations of connected domains sampled a range
from compact to extended conformations, covering the lower
region of the interdomain separationsmeasured byEM(6). In
fact, compact conformations are expected from a direct A1-
A2 interaction, as established in previous assays (30) and
confirmed in our AFM experiments. Also, the presence of a
third domain (e.g., D’D3 or A3) or deposition on the surface
may favor more extended conformations in the EM experi-
ments compared with the ones sampled in our simulations.
Autoinhibition driven by A1-A2 interactions provides a
molecular picture of the shielding of the GPIba (platelet)
binding site, crucial to maintain the VWF inactive under
equilibrium conditions. This is a complementary scenario
to previous shear-dependent models (18,20) for GPIba
binding, but is the only one reconciling previous inactiva-
tion experiments (30).Biophysical Journal 108(9) 2312–2321Main orientational modes of the autoinhibited
state
From our simulations, the minimum structural requirement
to block GPIba binding is to have A1-A2 binding and this
is effectively achieved by the A2 domain specifically target-
ing the GPIba binding site in A1. Our docking calculations
and further extensive MD refinement narrowed the interdo-
main conformational variability to two main orientational
modes of blockage, stabilized by an attractive interdomain
potential energy and a reduction in the amount of solvent
accessible hydrophobic surface (Fig. 2). A2 located either
with its C terminus or with its b3 strand in proximity to
the b3 strand of A1, resulting in a quasi-extended cross-
domain b-sheet in the latter case. Notably, as a general
feature, the A2 domain obstructs the A1-domain b3 strand
(which connects to GPIba (15,16)), thus suggesting drastic
VWF autoinhibition. Direct blockage of the main interac-
tion partner of GPIba in the A1 domain (the b3 strand)
was also observed in our simulations started from unbiased
positions, with the domains separated, further supporting
our proposed mode of autoinhibition. In addition, the agree-
ment between our force-probe MD simulations and AFM
experiments (see below) stresses on the validity of the cho-
sen conformations from docking, followed by MD refine-
ment, and the robustness of the MD simulation results.
Our structural predictions are anticipated to motivate future
structural studies aiming at determining the structure of
the A1-A2 complex, in the nonconnected and connected
situations, both of physiological relevance. Mutants
Arg1668Asp, Asp1587Lys, and Val1548Ser(Asn) may serve
as initial candidates for mutagenesis studies to discern
among the two proposed modes of blockage.
In the simulations started from separated domains, addi-
tional blocking orientations were observed. Here, the pres-
ence of the N-linked sugars or the O-glycosylated linker
may also play stabilization roles. An additional stabilization
of the blocked (autoinhibited) state of the VWF by the
sugars is consistent with recent microfluidic experiments
that showed an increase in platelet adhesion when the
VWF was N-deglycosylated (46).Force unblocks the GPIba-binding site before
exposure of the ADAMTS13 cleavage site,
ensuring VWF activation before cleavage
In our force-probe simulations, we induced the dissociation
of the complex formed by the A1 and A2 domains by
applying an external stretching force. In complex, the
VWF A2 domain showed only marginal unfolding, which
proceeded from the C terminus, in line with the unfolding
mechanism previously observed for this domain in isolation
(with different force fields) (23,47). Dissociation was found
to occur before exposure of the ADAMTS13 cleavage site in
the A2 domain with a very high probability (~0.88) (Fig. 3).
Von Willebrand Factor Autoinhibition 2319This is consistent with our AFM measurements, which
yielded in the majority of the binding events small elonga-
tions of the VWF-A1A2 complex at rupture (Fig. 4). Our
simulations and AFM thus support that a stretching force
unblocks the GPIba-binding site, by detaching the A1 and
A2 domains, and that this process is coupled to the exposure
of the ADAMTS13 cleavage site in the A2 domain after its
unfolding. The stretching force ensures, however, that the
VWF is activated for platelet binding predominantly before
deactivation through cleavage. In this respect, the interac-
tions between A1 and A2 may also serve to clarify the
role of ristocetin, coupling platelet binding and ADAMTS13
cleavage (48).Deletion of the A2 domain results in a VWF with a
gain of function
Our microfluidic experiments showed a reduction of the
critical shear-rate for the formation of VWF-platelet fibers
and rolling aggregates, when the A2 domain was deleted.
This implies a VWF with a gain in function (Fig. 5). Our re-
sults in consequence expand the experiments by Martin
et al. (30), proving that not only present in solution but
also within the VWF molecule, the A2 domain critically in-
fluences platelet binding in a shear-dependent manner. In
addition, our combined computational and experimental re-
sults suggest that the A2 domain stabilizes a VWF inactive
state, by direct A1-A2 interactions, either within or across
VWF monomers. However, additional inhibitory mecha-
nisms must be at play, because the DA2-VWF mutant still
requires intermediate shear rates for the formation of rolling
aggregates (2500 s–1 for DA2-VWF instead of 4000 s–1 for
the wild-type VWF). We speculate that the exposure of the
GPIba binding site requires both a global globule-to-stretch
transition, eventually involving other—specific or nonspe-
cific—domain-domain interactions (e.g., between D’D3
and A1 (28)), and VWF-A1A2 dissociation.CONCLUSIONS
In this study, we examined the inactivation of VWF for
platelet binding, induced by a specific domain-domain inter-
action, and its coupling to VWF cleavage degradation driven
by force, by using MD simulations, molecular docking,
AFM, and microfluidic experiments. We demonstrate that
under equilibrium conditions the VWFA1 and A2 domains
bind to each other, with the A2 domain specifically targeting
the GPIba binding site in the A1 domain, thus blocking the
binding ofGPIba (and thereby of platelets) to VWF. This im-
plies autoinhibition of the VWFmediated by A1-A2 interac-
tions. We identified two main orientational blocking modes,
which have the shielding of the A1 b3 strand, the site critical
for GPIba binding, in common. Detachment of the two do-
mains, induced by a stretching force, unblocked the GPIba
binding site most predominantly before exposure of thecleavage site in the A2 domain. This suggests that A2 blocks
GPIba binding in a force-dependent manner, but guarantee-
ing that the VWF is ready for activation before cleavage, to
mechanically balance the propagation and attenuation of he-
mostasis. Deletion of the A2 domain enhanced platelet bind-
ing, corroborating the key autoinhibition role of this domain.
In summary, our results suggest, to our knowledge, a new in-
terdomain-mediated autoinhibition mechanism that explains
the inactivation of VWF under equilibrium conditions while
allowing shear-sensitive growth of blood coagulates. This
mechanism reconciles previous and can be tested by future
experiments. It will be highly interesting to investigate if
this or other domain-domain interactions are a common reg-
ulatory mechanism, not only for the shear-sensitive binding
of VWF to its partners, but also potentially for the shear-
dependent self-aggregation of VWF.SUPPORTING MATERIAL
Supporting Materials and Methods, seven figures, and one movie are avail-
able at http://www.biophysj.org/biophysj/supplemental/S0006-3495(15)
00302-1.
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